1. |
---|
In support of the HHS Bridge Access Program for COVID-19 Vaccines and Treatments, HRSA is making funding available to health centers to continue essential COVID-19-related services and mitigate adverse impacts of COVID-19 on underserved populations as COVID-19 vaccines and therapeutics move to the commercial market beginning in the fall of 2023. Approximately $81.1 million is available to health centers through Health Center Program COVID-19 Bridge Access Program funding (Bridge funding). Health centers will use these one-time funds to support patients and residents of their communities, including uninsured and underinsured individuals by:
|
2. | |
---|---|
1. Login to EHBs. | |
2. From the EHBs home page, click the Tasks tab to view the Pending Tasks - List page. | |
3. The Bridge Progress Report task will show 'Progress Report' in the 'Task' column and will show your Bridge grant number in the 'Entity' column. | |
4. Click the Start or Edit link in the 'Options' column to begin your progress report. |
3. | |
---|---|
1. On the Progress Report - Status Overview page, you will see the applicable forms to complete the Bridge Progress Report. The report consists of three forms:
| |
2. Click the Update link in the 'Options' column next to the Contact Information Form. | |
3.1 Completing the Contact Information Form | |
1. Enter the contact information for the point of contact for your Bridge progress report. | |
2. Click the Save and Continue button to proceed to the Bridge Form. | |
3.2 Completing the Bridge Form | |
1. Complete the following questions on the Bridge Form. | |
Question 1: Bridge Access Program Project Status
| |
Question 2: Please provide a status report on all activities supported with the HRSA-approved Bridge Access Program for COVID-19 Vaccines and Treatment submission. For each activity included in the approved Activities List, select "Complete", "In Progress", or "Not Started". Select "NA" ONLY if the activity was not included in your approved Activities List. You must describe specific activities conducted during the reporting period as a part of the successes and lessons learned/promising practices.
| |
Question 3: Are the activities described above and associated uses of the funds consistent with you approved Bridge Access Program for COVID-19 Vaccines and Treatment award submission?
| |
Question 4: Did you encounter any significant barriers in the use of the funding and/or implementing the planned activities in this reporting period?
| |
Question 5: Point in Time Impact Self Assessment:
| |
Question 6: Please select all applicable responses below regarding training and technical assistance (T/TA) related to this award. | |
2. Click the Save and Continue button to proceed. | |
3.3 Completing the Final Report Narrative Form | |
1. The Final Report Narrative Form should only be completed if this is your final progress report. In your final report, you should mark the project "Completed" on the Bridge Form. 2. Complete the following questions on the Final Report Narrative Form: | |
Question 1: Is this your final report? | |
Question 2: Project Status
| |
Question 3: Provide a detailed narrative for all FY2023 Bridge Access Program activities.
| |
3. Click the Save and Continue button to proceed to the Review page. |
4. | |
---|---|
1. On the Review page, review your progress report forms to ensure that all information entered is accurate. Access each form by clicking on the View link in the 'Options' column. Click on the Continue button to proceed to the Submit Report page. | |
2. On the Submit Report page, click on the Submit button to submit your progress report to HRSA. |
5. |
---|
1. After submitting the Bridge Progress Report, HRSA may determine that additional information or corrections are needed to what was originally submitted.
|
2. If a change request is sent, your progress report will be accessible to you immediately in your pending tasks queue. Follow the steps found in section 2. Accessing the Bridge Progress Report to revisit and update the information in your progress report consistent with the email notification. |